Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(4-((2-oxocyclohexylidene)methyl)phenyl)propionic Acid
2. 2-ocmpp
3. Cs 670
4. Cs-670
1. 69956-77-0
2. Pelubiprofen [inn]
3. Rs-2131
4. Cs-670
5. 2-[4-[(e)-(2-oxocyclohexylidene)methyl]phenyl]propanoic Acid
6. 1619c79fvj
7. Ncgc00183010-01
8. 2-ocmpp
9. Unii-1619c79fvj
10. Cs 670
11. Pelubiprofen (jan/inn)
12. Pelubiprofen [jan]
13. Dsstox_cid_28721
14. Dsstox_rid_82990
15. Dsstox_gsid_48795
16. Dw330sr
17. Chembl69308
18. Pelubiprofen [who-dd]
19. Schembl188062
20. Dw-330sr
21. Gtpl9876
22. Dtxsid2048795
23. (+-)-p-(((e)-2-oxocyclohexylidene)methyl)hydratropic Acid
24. Tox21_113272
25. Db12150
26. Compound 13b [pmid: 6607354]
27. Hy-12383
28. Cas-69956-77-0
29. Cs-0011235
30. D01865
31. Q27251763
32. (e)-2-[4-[(2-oxocyclohexylidene)methyl]phenyl]propanoic Acid
33. Benzeneacetic Acid, Alpha-methyl-4-((2-oxocyclohexylidene)methyl)-
34. [r,(?)]-2-[4-[((e)-2-oxocyclohexylidene)methyl]phenyl]propionic Acid
35. [s,(+)]-2-[4-[((e)-2-oxocyclohexylidene)methyl]phenyl]propionic Acid
36. Benzeneacetic Acid, .alpha.-methyl-4-((2-oxocyclohexylidene)methyl)-, (e)-
Molecular Weight | 258.31 g/mol |
---|---|
Molecular Formula | C16H18O3 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 258.125594432 g/mol |
Monoisotopic Mass | 258.125594432 g/mol |
Topological Polar Surface Area | 54.4 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 376 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
47
PharmaCompass offers a list of Pelubiprofen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pelubiprofen manufacturer or Pelubiprofen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pelubiprofen manufacturer or Pelubiprofen supplier.
PharmaCompass also assists you with knowing the Pelubiprofen API Price utilized in the formulation of products. Pelubiprofen API Price is not always fixed or binding as the Pelubiprofen Price is obtained through a variety of data sources. The Pelubiprofen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DW330SR manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DW330SR, including repackagers and relabelers. The FDA regulates DW330SR manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DW330SR API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A DW330SR supplier is an individual or a company that provides DW330SR active pharmaceutical ingredient (API) or DW330SR finished formulations upon request. The DW330SR suppliers may include DW330SR API manufacturers, exporters, distributors and traders.
click here to find a list of DW330SR suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DW330SR Drug Master File in Korea (DW330SR KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DW330SR. The MFDS reviews the DW330SR KDMF as part of the drug registration process and uses the information provided in the DW330SR KDMF to evaluate the safety and efficacy of the drug.
After submitting a DW330SR KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DW330SR API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DW330SR suppliers with KDMF on PharmaCompass.
DW330SR Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DW330SR GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DW330SR GMP manufacturer or DW330SR GMP API supplier for your needs.
A DW330SR CoA (Certificate of Analysis) is a formal document that attests to DW330SR's compliance with DW330SR specifications and serves as a tool for batch-level quality control.
DW330SR CoA mostly includes findings from lab analyses of a specific batch. For each DW330SR CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DW330SR may be tested according to a variety of international standards, such as European Pharmacopoeia (DW330SR EP), DW330SR JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DW330SR USP).